Bleakley Financial Group’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,608
| Closed | -$246K | – | 559 |
|
|
2024
Q4 | $246K | Buy |
1,608
+535
| +50% | +$81.8K | 0.01% | 874 |
|
|
2024
Q3 | $208K | Sell |
1,073
-759
| -41% | -$147K | 0.01% | 914 |
|
|
2024
Q2 | $425K | Sell |
1,832
-231
| -11% | -$53.6K | 0.01% | 655 |
|
|
2024
Q1 | $445K | Sell |
2,063
-228
| -10% | -$49.2K | 0.01% | 645 |
|
|
2023
Q4 | $593K | Buy |
2,291
+270
| +13% | +$69.9K | 0.02% | 541 |
|
|
2023
Q3 | $519K | Sell |
2,021
-638
| -24% | -$164K | 0.02% | 534 |
|
|
2023
Q2 | $757K | Buy |
2,659
+118
| +5% | +$33.6K | 0.02% | 476 |
|
|
2023
Q1 | $706K | Sell |
2,541
-45
| -2% | -$12.5K | 0.02% | 483 |
|
|
2022
Q4 | $716K | Buy |
+2,586
| New | +$716K | 0.03% | 453 |
|